Corrado Advisors, LLC Incyte Corp Transaction History

Corrado Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 09, 2019	SELL	$58.5 - $69.94 $629,401 - $752,484	-10,759 Closed	0 $0
Q3 2018 Oct 11, 2018	SELL	$61.75 - $74.23 $108,124 - $129,976	-1,751 Reduced 14.0%	10,759 $743,000
Q2 2018 Jul 09, 2018	BUY	$60.85 - $83.98 $28,051 - $38,714	461 Added 3.83%	12,510 $838,000
Q1 2018 Apr 06, 2018	SELL	$83.06 - $100.98 $80,402 - $97,748	-968 Reduced 7.44%	12,049 $1 Million
Q4 2017 Jan 10, 2018	BUY	$93.56 - $116.6 $357,492 - $445,528	3,821 Added 41.55%	13,017 $1.23 Million
Q3 2017 Oct 06, 2017	BUY	$109.15 - $138.27 $1 Million - $1.27 Million	9,196	9,196 $1.07 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corrado Advisors, LLC with notifications on news.